Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.48286 | 19 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.49029 | 21 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.46366 | 19 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.54786 | 60 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.42938 | 20 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.49368 | 18 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.46457 | 18 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.45317 | 20 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.44878 | 20 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.75012 | 34 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.45949 | 20 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.45082 | 20 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.45966 | 19 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.43117 | 18 |